One of the missions at the CIB Margarita Salas-CSIC consists in making available to society the knowledge and the research results generated in our research center. Thus, we aim to convert our basic research findings into tangible applications, either through the generation and licensing of intellectual property, and/or through the generation of spin-off companies. Currently the CIB Margarita Salas has 8 EBTs considered CSIC spin-offs: Secugen, Protein alternatives, Lifesequencing (now ADM-Lifesequencing), Ankar Pharma, Abvance Biotech, Arrays for Cell Nanodevices (A4CELL), Microbial Biosystems and AItenea Biotech a EBT already constituted (Jun 2020) which will become a CSIC spin-off in the next weeks. In addition, HelpRare is in the process to become a EBT in the coming months and we also had recently the spin-off ProRetina Therapeutics, which closed last year (2007-2019).

 

     Secugen logo            lifesequencing logo   

 

 

Ankar Pharma logo        Abvance     

 

 

Proalt Alternatives logo                 A4Cell logo   

 

 

                       Microbial B logo   

 

                               AItenea logo

  

                                   Help Rare logo